Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it has acted as Financial PR & Investor Relations advisor for the AIM IPO of Belluscura plc (AIM: “BELL”), a
leading medical device developer focused on lightweight and portable oxygen enrichment technology. The team at Walbrook will now manage the Company’s communications with the financial media, research analysts and non-institutional investors,
including new and existing private investors.
On admission, Belluscura plc completed a successful placing for gross proceeds of £17.5 million, with a market capitalisation of approximately £50.96 million.
Belluscura was established in the UK in December 2015 with the object of commercialising intellectual property in the medical device space. The Company is focused on devices and treatments involving enriched oxygen
Belluscura currently has three significantly differentiated portable oxygen concentrators in its portfolio:
The Company expects to launch the X-PLO₂RTM in July 2021 with online distributors with the X-PLO₂R CX targeting launch in December 2021 and expected to be available in the market from January 2022 onwards. The X-PLO₂R DX is expected to launch
in March 2022.
Paul McManus, Founder and Managing Director of Walbrook PR, commented: “We are delighted to work with Belluscura and congratulate the company on their AIM IPO today. BELL is a very exciting company with a portfolio of significantly differentiated portfolio of portable oxygen concentrators which are expected to substantially improve the current standard-of-care.
“We look forward to developing the Company’s profile with analysts, investors and journalists as they begin this exciting new chapter.”
For more information visit the Company’s website: https://www.belluscura.com/
For further information please contact:
About Walbrook PR:
Walbrook PR was founded in April 2009 by Paul McManus and focuses on providing high quality Financial PR and Investor Relations to Small Cap and AIM listed companies.
Walbrook PR is ranked #2 by number of AIM listed companies with 50 AIM listed clients (Source: AIM Advisers Rankings Guide, October 2021) and ranked #7 by total number of stock market listed clients (Corporate Advisers Rankings Guide, August 2021) advising a total of 58 stock market listed companies across a wide mix of sectors.
Walbrook PR prides itself on having a strong reputation for working with growing UK Small Cap and AIM listed companies; a proven IR offering, which focuses on the Private Client Investment Management community and the retail investment community; and on having a proactive, hands-on approach from a committed team with full ownership of the business.